Randy L. Jensen,
MD, PhD
Languages Spoken: English, Japanese
Labs: Website
Dr Randy Jensen is a neurosurgeon with a clinical practice focused on treating patients with brain tumors. He has extensive experience utilizing novel surgical methods to maximize tumor removal and minimize surgical complications. He is an expert on the use of preoperative planning and imaging to remove tumors from eloquent areas of the brain. He routinely performs awake craniotomy with intraoperative cortical mapping to avoid motor or speech injury during removal of tumors near these areas of the brain. He has instituted an intraoperative MRI program, the only one available in the Intermountain West. He also co-directs the Stereotactic Radiosurgery program which utilizes the Brain Lab Novalis Frameless Shaped Beam System for precise delivery of radiation for treatment of benign and malignant brain tumors. He and Dr Dennis Shrieve have treated over 1000 patients using these techniques.
Dr Jensen is Professor of Neurosurgery, Radiation Oncology and Oncological Sciences. He is a member of both the Experimental Therapeutics and the Nuclear Control of Cell Growth and Differentiation programs. He has served at a national level for various Neurosurgical Societies and was recently President of the Rocky Mountain Neurosurgery Society. He is the Associate Program Director for the Neurosurgery Residency program and Clerkship Director for medical students rotating on the Neurosurgery Service.
He is a Cancer Research Investigator at the Huntsman Cancer Institute and has a laboratory focused on animal models of meningioma and radiation necrosis. His laboratory studies brain tumor hypoxia and angiogenesis. He is the author of over 100 papers most on topics of brain tumor biology and patient outcome after brain tumor treatment.
He has been the principal investigator of many brain tumor clinical trials and continues to offer cutting edge treatments for patients with brain tumors.
Dr. Randy Jensen specializes in Neurosurgery, Brain Tumors, Skull Base Surgery, Neuro Trauma and Neurocritical Care. He has a particular emphasis using preoperative imaging, intraoperative navigation, intraoperative cortical mapping and intraoperative MRI to maximize tumor resection and minimize surgical complications. He treats patients with malignant, benign, and metastatic brain tumors. He has many clinical trials for patients with brain tumors and has a laboratory effort examining brain tumor biology. He is also a member of the Brain Tumor Research Team at Huntsman Cancer Institute.
Clinical Locations
801-585-6065
Patient Care Center
801-585-0260
Board Certification and Academic Information
| Academic Departments | Neurosurgery
-
Professor Oncological Sciences - Adjunct Professor Radiation Oncology - Adjunct Professor |
| Academic Divisions | Adult Neurosurgery |
| Board Certification | American Board of Neurological Surgery (Neurosurg) American Board of Neurological Surgery (Neurosurg) |
| Cancer Center Programs | Experimental Therapeutics |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.8/ 5
Care provider spoke using clear language
4.8/ 5
Care provider's explanation of condition/problem
4.8/ 5
My confidence in care provider
4.8/ 5
Care provider's effort to include me in decisions
4.8/ 5
Wait time at clinic
4.5/ 5
Time care provider spent with me
4.6/ 5
Care provider's concern for questions & worries
4.7/ 5
Care provider's friendliness and courtesy
4.8/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
April 30, 2019
I appreciate the time he took with me explaining what SMA was and how it had effected me and what SMA stood for.
UofU Patient
April 19, 2019
given my situation, I felt like I had the best team and care possible. I truly had a great experience.
UofU Patient
April 15, 2019
I wish I could fill in a box that said "Outstanding" because that is the type of service I received from minute one.
UofU Patient
March 02, 2019
dr Jensen is the best! always remembers who I am and my family.
UofU Patient
February 27, 2019
The therapist answered all my questions and seemed friendly.
UofU Patient
February 06, 2019
dr Jensen is truly amazing! so kind and clearly very good at his job!
UofU Patient
February 04, 2019
Great experience with Dr. Jensen. I would definitely recommend him.
UofU Patient
January 27, 2019
Everyone from Registration to Radiology Techs were super kind and very friendly. Melody is always so kind and 1000% on top of everything. Dr Jensen is an incredible Dr. Dr Jensen is not only incredibly smart he's willing to sit and go over scans and problems to find the best solutions. Top notch.
UofU Patient
December 19, 2018
Dr. Jensen is INCREDIBLE! I thought I would be an emotional mess after my consult but all my fears and concerns were calmed and I felt 100% confident in him and the care I would receive! This is HUGE especially for someone with my crazy medical history
UofU Patient
October 29, 2018
I was referred by Dr. Peoples in Henderson Nevada, his shoes are very hard to fill and I can tell you Dr. Jensen was exactly like Dr. Peoples!
UofU Patient
October 28, 2018
Dr. Randy Jensen is an excellent doctor both in skill and compassion.
UofU Patient
October 05, 2018
extremely professional
UofU Patient
September 29, 2018
Dr. Jensen was very helpful, explanation of procedure helped ease the stress and anxiety of the unknown. He expressed concern for my health and that really made me feel like I was on good hands
UofU Patient
September 12, 2018
Doctor Jensen is fenominal
UofU Patient
July 16, 2018
Doctors care was greatly in depth and understanding with myself and family in mind!
UofU Patient
June 19, 2018
Overall Good Experience!
UofU Patient
June 16, 2018
Was very caring and explained everything I wanted to know thoroughly! Answered every question I had and was kind and patient.
UofU Patient
June 13, 2018
I have been with Dr. Jensen for years and he is still as terrific as when I first met him.
UofU Patient
May 19, 2018
everyone at the Huntsman was absolutely amazing. We were treated with dignity, respect, had all of our questions/concerns addressed. Bedside manner was spot on, not one complaint from our family on the Huntsman team! Dr. Jensen was a gem, so thankful to have him on the care team. You guys are the best!!! Thank you for the loving care provided to our mom!!
UofU Patient
May 02, 2018
I would recommend Dr. Jensen to any one that has an issue.
UofU Patient
April 20, 2018
Once again there needs to be an excellent box to check. I am soo grateful to have care providers that I have. They not only care for me they care about me. They make you feel like you are the single most important person in the world.
UofU Patient
March 24, 2018
Dr Jensen is terrific.
UofU Patient
March 21, 2018
I have given uo,you just wanted me to leave
UofU Patient
January 08, 2018
dr. Jensen offered to personally call me after getting another opinion the next day , which he followed through with!
UofU Patient
November 25, 2017
I was treated very well. The staff and Dr Jensen were very personable and explained everything going on perfectly. I'm so thankful for y'all.
UofU Patient
October 29, 2017
so far fantastic
UofU Patient
October 25, 2017
Dr. Jensen is so friendly and funny. I have seen Dr. Jensen for 12 years and feel very confident in his treatment.
UofU Patient
October 23, 2017
I am very impressed and wouldn't choose to go anywhere else
UofU Patient
October 20, 2017
I really like Dr. Jensen and would recommend him to any one that asked who I was seeing.
UofU Patient
September 02, 2017
good experience
UofU Patient
July 14, 2017
I love Dr Jensen. he and Melody always make my day a bit brighter. i teust Dr J with all my brain needs!
UofU Patient
July 05, 2017
Wonderful physician! Outstanding "bedside manner!"
UofU Patient
June 27, 2017
good
UofU Patient
June 17, 2017
I love Dr. Jensen
UofU Patient
April 24, 2017
The only thing I can say is I wish he could have given me a little more info about what could go wrong.
UofU Patient
April 11, 2017
All my questions were discussed, and discomforts were not disregarded.
UofU Patient
March 11, 2017
No better surgeon than Dr. Jensen. It is a privilege to be one of his patients.
UofU Patient
March 11, 2017
I have and will continue to recommend patients to Dr. Jensen. He is kind, personable, and always involves me in decisions.
UofU Patient
March 04, 2017
Dr jensen is always a kind man
UofU Patient
December 24, 2016
incredible teamDr Jensen and team spent over an hour reviewing scans and explaining radiology report
UofU Patient
December 14, 2016
I really like and feel confident with Dr. Randy Jensen
UofU Patient
September 17, 2016
please don't change a thing. thank you so much
UofU Patient
August 29, 2016
I love Dr. Jensen. He is absolutely amazing.
UofU Patient
August 27, 2016
Will definitely recommend. I would not want to go to anyone else.
UofU Patient
August 27, 2016
Terrific care
UofU Patient
July 09, 2016
Feel very blessed to be in the care I have received and know I will receive in the months ahead.
UofU Patient
July 03, 2016
The whole staff in radiation is wonderful - caring and kind and compassionate and informative.
UofU Patient
May 26, 2016
I felt respected and safe
UofU Patient
May 23, 2016
excellent service
UofU Patient
May 21, 2016
I couldn't get a better experience. I am so happy with my visit there
UofU Patient
May 02, 2016
this was only a follow up visit with very few active issues to discuss.
UofU Patient
April 29, 2016
Dr Jensen couldn't do better at addressing the problem at hand; we feel confidence in his expertise and in his ability to counsel regarding the status of the medical problem
UofU Patient
April 27, 2016
Dr. Randy Jensen is fantastic.
UofU Patient
April 26, 2016
we will and have told people to go to the Huntsman truly the best Hospital and staff ever
UofU Patient
March 15, 2016
This is the greatest doctor ever he takes time to do anything he can for his patients!!!!
UofU Patient
March 05, 2016
Very good
UofU Patient
January 30, 2016
I never felt rushed. Everything was explained to me very clearly.
UofU Patient
January 30, 2016
Even though the physician was unable to do anything further for my condition, he made sure other physicians were informed and appointments for that care were made without hesitstion and I was contacted regarding when and where they were.
UofU Patient
January 10, 2016
Dr Jensen is awesome. He is most personable and competent Dr I have ever met. Definitely a keeper!!
UofU Patient
January 06, 2016
I left with no answers and still don't have them! It's very discouraging
UofU Patient
December 07, 2015
DR. Jensen reviewed my MRI and showed where the changes were and answered all of our questions. He was very approachable, knowledgeable and helpful.
UofU Patient
November 20, 2015
I feel like Dr. Jenson and melody treat me as if they were treating one of their own family members!! I feel like they truly care and do there absolute best when helping me to understand my condition and medication I'm taking. I'm truly blessed to have a doctor like him, and nurse that I can call at any moment and never feel like an inconvenience. Thank you so much!!
UofU Patient
November 14, 2015
I saw several doctors. They each answered my questions. I was impressed by the care they took to ensure I understood their answers.
UofU Patient
October 27, 2015
Dr. Jensen, is a wonderful Dr. Very friendly and caring. He took extra time to talk to us about our daughter who just had brain surgery. We love how easy it is to talk to him! A big thank you to him and his great staff!
UofU Patient
October 18, 2015
I know I had to wait a long time but I didn't feel like my time with the doctor got rushed in any way to catch up, which I appreciated.
UofU Patient
October 14, 2015
A doctor that can make you smile inspite of your problems.
UofU Patient
October 12, 2015
good
UofU Patient
October 10, 2015
My greatest contact has been with a physician assistant and these answers are just for him. Otherwise it becomes an average.
UofU Patient
September 09, 2015
love all care providers in this department
UofU Patient
August 30, 2015
Dr. Jensen is just so approachable, compassionate, and friendly. He directed his conversation to my 17 year-old daughter right at the onset, and he made her feel so comfortable.
UofU Patient
August 22, 2015
Both Dr.s Jensen & Coleman were very good about helping me explore all my options
UofU Patient
June 27, 2015
I am putting me complete confidence in the Huntsman Team.
UofU Patient
June 11, 2015
Dr. Jensen is so personable and makes you feel at ease the minute he steps into the exam room. He makes you feel as though you are the only one he is concerned about and it is easy to ask him any question you might have.
UofU Patient
June 10, 2015
I was impressed with the amount of time Dr. Jensen spent with me. it was very reassuring.
UofU Patient
June 02, 2015
Exceptional enter.
UofU Patient
April 26, 2015
Dr. Jensen has been my doctor for many years. I came to Dr. Jensen after losing all confidence in the doctor in Idaho Falls, ID. I am very comfortable and confident in Dr. Jensen. For me that is half the battle.
UofU Patient
March 12, 2015
Dr Jensen is always upfront and honest
UofU Patient
March 10, 2015
I could not be more happy From our Head Mechanic (surgeon) Oncology all of the staff right down to and including the nice person who would come and cleanour room. Thankyou very much
UofU Patient
February 14, 2015
Dr. Jensen is fantastic. I appreciate his down to earth nature and attention to my situation.
UofU Patient
January 24, 2015
dr Jensen is brilliant, empethetiic and communicates medical info and choices in terms I understood
UofU Patient
January 18, 2015
Had a meeting at the same time as my appt..felt a little rushed
UofU Patient
January 11, 2015
Dr Jensen is always so positive and helpful. I actually look forward to seeing him every 2 years.
UofU Patient
January 01, 2015
Dr. Jensen is expert yet humble. Friendly, humorous yet thorough and confident. I appreciate confidence.
UofU Patient
December 26, 2014
I am at ease that Dr. Jensen and his Team have my best interests at heart.
UofU Patient
December 05, 2014
very good experience
UofU Patient
December 02, 2014
Dr. Jensen is so good to work with and wonderful to explain what might be going on at this time in my life. I feel as if his comments are honest and complete with what information he has been given. I so appreciate him and the staff and the help they have provided for me.
UofU Patient
November 14, 2014
The care givers have been incredible! I am planning on bringing up ice cream next week for them to share. Thank you all!!
UofU Patient
November 07, 2014
I've heard rave reviews about Huntsman. They're true!
UofU Patient
November 01, 2014
I wanted Dr. Jensen's opinion on the problem I have been having. I trust his opinion because he gave my husband excellent care, as well as his concern for me and my family.
UofU Patient
October 31, 2014
We were very impressed that the Dr. took the time to call us himself about the results of the team meeting.
UofU Patient
October 14, 2014
Dr. Jensen always has a smile on his face. We think he's great!
UofU Patient
September 10, 2014
Love Dr. Jensen and Melody. They make my visits not so intimidating.
UofU Patient
August 29, 2014
excellent physician
UofU Patient
August 16, 2014
Instead of Very Good everything was excellant.
UofU Patient
July 24, 2014
We understand that there are often "wait" periods....however, we know that when it is our turn the same unrushed time will be given us to be sure we leave the visit with questions answered and assured that someone "is in our corner!"
UofU Patient
July 19, 2014
we learned a lot that we didn't learn elsewhwere. we were very impressed by how knowledgeable the doctors and the physicians assistant were. Yet they took time with us and treated us like we were important. This was a wonderful experience.
UofU Patient
July 15, 2014
As good of an experience as a person can have going through this.
UofU Patient
July 13, 2014
Dr. Jensen is great, he is very attentive to what my concerns are and answers all my questions.
UofU Patient
July 07, 2014
Everything was great, but I feel that more emphasis on the impact of the surgery would have helped.
UofU Patient
June 13, 2014
Dr. Jensen was friendly and down-to-earth in this approach and willing to let me make decisions on my care.
UofU Patient
May 19, 2014
We were/are extremely pleased with our experience. When a family is in such a situation having health care persons who care, who listen, who are helpful is critical, Dr Jensen and his staff provided that comfort to us. Having traveled a distance and not knowing anyone, this eased our minds greatly.
UofU Patient
April 28, 2014
Dr was great. Answered all my questions and I do not need any medications. I left feeling very good about my visit.
UofU Patient
April 05, 2014
I really like Dr.Jensen
UofU Patient
March 21, 2014
I love Dr Jensen and will always see him for my tumor
UofU Patient
March 16, 2014
Dr Jensen is very personable and makes my husband and I feel like I am his only patient!
UofU Patient
February 15, 2014
Dr. Randy Jensen is so wonderful.He is so kind,thoughtful,and patient.I absolutely feel like he saved my life and I truly trust him with my medical care.
UofU Patient
February 14, 2014
Always a good experience with Dr. Jensen
UofU Patient
February 02, 2014
Dr Randy Jensen was excellent as were the other members of team that I dealt with during my visit
UofU Patient
January 25, 2014
We really like Dr Randy Jensen. Besides being very knowledgeable, he is so friendly and caring.
UofU Patient
January 06, 2014
Given the reason we were there our experience could not have been a better one based on the helpfulness of all the caregivers that we dealt with
UofU Patient
January 02, 2014
Loved the doctor (neurosurgeon)
UofU Patient
December 21, 2013
Dr, Jensen seems to remember me even though I come every two years.
UofU Patient
November 08, 2013
We love Dr Jensen. He is very understanding and takes all the time we need to understand. He explains things so we understand them. He is understanding and sensitive to the stress of our situation.
UofU Patient
September 23, 2013
Wonderful and caring treatment and attention to detail. Great confidence booster.
UofU Patient
September 09, 2013
The were great.
UofU Patient
August 12, 2013
He was very personable and friendly.
UofU Patient
August 02, 2013
I actually have referred a friend to dr Jensen and they also loved him!
UofU Patient
July 04, 2013
There were many positive connections that we could use to support confidence.
UofU Patient
June 19, 2013
Dr. Jensen is one of the kindest, most professional, knowledgeable, caring, comforting, and downright pleasant physicians with whom I have ever interacted. He is an excellent physician technically and delightful personally.
UofU Patient
June 10, 2013
Dr. Jensen is a jedi master. Total confidence in him
UofU Patient
June 03, 2013
The doctor was caring and personable.
UofU Patient
June 03, 2013
Love Dr Jensen. So friendly and engaging. Knowledgeable. Caring.
UofU Patient
February 25, 2013
Dr. Randy Jensen is always so kind and caring to me and my situation. I have nothing but wonderful things to write about him and his staff. I feel like he actually saved my life. Because of him and his expertise in the neurological field , he has changed my life and my health. My family and I am so grateful to him for this gift.
UofU Patient
February 18, 2013
I appreciate Dr. Jensen always being so forthright with me.
UofU Patient
December 17, 2012
They all seemed very helpful and concerned.
UofU Patient
December 09, 2012
Dr. Jensen has been very helpful in addressing my concerns about ongoing migraines. His considerate attitude is exceptional.
UofU Patient
October 03, 2012
Doctor Jensen treated our son with kindness and answered all of his questions as well as ours, and we had a lot of them (questions). He has the best bedside manner and such a comforting smile, we feel very fortunate to have him as our son surgeon.
UofU Patient
September 10, 2012
Thank you to all who are involved
UofU Patient
September 03, 2012
Incredible. Dr. Jensen is not only extremely knowledgeable, but friendly and funny - what a wonderful combination:-)
UofU Patient
August 13, 2012
Randy is the best he makes sure I understand what is going on and is very quick to reply to phone calls, emails, and makes me feel like a person not just a client with a specific number
UofU Patient
August 07, 2012
My wife and I love Dr. Jensen. From the start after first learning about my wife's brain tumor we felt the utmost confidence in his abilities and he has been very compassionate and caring throughout the diagnosis, surgery and follow up. In our last visit I wish we could have spent a little more time with him as it was really short and we left kind of feeling like "that's it?" This has been a life altering experience for us and we worry and wonder a lot about the future and would have liked to have had a little more time with him but I understand that he is very busy and I think that the outcome of my wife's surgery has been so good in his eyes that maybe he felt like she was doing so good that there wasn't much else to tell us. Regardless, he is a very good man and we feel fortunate to have had him as our neurosurgeon.
UofU Patient
July 29, 2012
Dr Jensen was very thorough and gave me every option I could choose for treatment without forcing me in any way.
UofU Patient
March 22, 2012
All elements in this group of questions were very good, and these are the most important questions.
UofU Patient
February 10, 2012
They underestimated the time to get the pathology report which kept us on pins and needles for a few extra days, so would have preferred to have it more accurate, but this was a small thing overall
Dr Randy Jensen is a neurosurgeon with a clinical practice focused on treating patients with brain tumors. He has extensive experience utilizing novel surgical methods to maximize tumor removal and minimize surgical complications. He is an expert on the use of preoperative planning and imaging to remove tumors from eloquent areas of the brain. He routinely performs awake craniotomy with intraoperative cortical mapping to avoid motor or speech injury during removal of tumors near these areas of the brain. He has instituted an intraoperative MRI program, the only one available in the Intermountain West. He also co-directs the Stereotactic Radiosurgery program which utilizes the Brain Lab Novalis Frameless Shaped Beam System for precise delivery of radiation for treatment of benign and malignant brain tumors. He and Dr Dennis Shrieve have treated over 1000 patients using these techniques.
Dr Jensen is Professor of Neurosurgery, Radiation Oncology and Oncological Sciences. He is a member of both the Experimental Therapeutics and the Nuclear Control of Cell Growth and Differentiation programs. He has served at a national level for various Neurosurgical Societies and was recently President of the Rocky Mountain Neurosurgery Society. He is the Associate Program Director for the Neurosurgery Residency program and Clerkship Director for medical students rotating on the Neurosurgery Service.
He is a Cancer Research Investigator at the Huntsman Cancer Institute and has a laboratory focused on animal models of meningioma and radiation necrosis. His laboratory studies brain tumor hypoxia and angiogenesis. He is the author of over 100 papers most on topics of brain tumor biology and patient outcome after brain tumor treatment.
He has been the principal investigator of many brain tumor clinical trials and continues to offer cutting edge treatments for patients with brain tumors.
Dr. Randy Jensen specializes in Neurosurgery, Brain Tumors, Skull Base Surgery, Neuro Trauma and Neurocritical Care. He has a particular emphasis using preoperative imaging, intraoperative navigation, intraoperative cortical mapping and intraoperative MRI to maximize tumor resection and minimize surgical complications. He treats patients with malignant, benign, and metastatic brain tumors. He has many clinical trials for patients with brain tumors and has a laboratory effort examining brain tumor biology. He is also a member of the Brain Tumor Research Team at Huntsman Cancer Institute.
Academic Locations
School of Medicine
801-581-6908
Board Certification and Academic Information
| Academic Departments | Neurosurgery
-
Professor Oncological Sciences - Adjunct Professor Radiation Oncology - Adjunct Professor |
| Academic Divisions | Adult Neurosurgery |
| Board Certification | American Board of Neurological Surgery (Neurosurg) American Board of Neurological Surgery (Neurosurg) |
| Cancer Center Programs | Experimental Therapeutics |
Research Interests
- Hypoxia, Brain
- Hypoxia Inducible Factor-1
- Calcium Channel Antagonists
- Cox-2
- Diphtheria toxin-conjugated monoclonal antibody
- IL-13 receptors
- Gliasite
- Phase II 131-I
- Stereotactic radiosurgery versus surgery for single brain metastasis
Education History
| Doctoral Training | Loyola University Medical Center Ph.D. |
| Residency | Loyola University of Chicago Neurosurgery Resident |
| Professional Medical | University of Utah Hospital School of Medicine Medicine M.D. |
| Undergraduate | University of Utah Chemistry B.A. |
| Undergraduate | University of Utah Biology B.S. |
| Fellowship | University of Utah Healthcare, Academy of Health Science Educators Fellow |
| Graduate Training | University of Illinois Neurosurgery MHPE |
Selected Publications - Journal Articles
Journal Article
- Ronna B, Guan J, Karsy M, Service J, Ekins A, Jensen RL (). A Survey of Neurosurgery Program Coordinators: Their Roles, Responsibility, and Perceived Value. Cureus, 11(4), e4457.
- Karsy M, Akbari SH, Limbrick D, Leuthardt EC, Evans J, Smyth MD, Strahle J, Leonard J, Cheshier S, Brockmeyer DL, Bollo RJ, Kestle JR, Honeycutt J, Donahue DJ, Roberts RA, Hansen DR, Riva-Cambrin J, Sutherland G, Gallagher C, Hader W, Starreveld Y, Hamilton M, Duhaime AC, Jensen RL, Chicoine MR (2019 Apr 12). Evaluation of pediatric glioma outcomes using intraoperative MRI: a multicenter cohort study.LID - 10.1007/s11060-019-03154-7 [doi]. (Epub ahead of print) J Neurooncol.
- Wilde H, Azab MA, Abunimer AM, Abou-Al-Shaar H, Karsy M, Guan J, Menacho ST, Jensen RL (2019 Mar 29). Evaluation of cost and survival in intracranial gliomas using the Value Driven Outcomes database: a retrospective cohort analysis. J Neurosurg, 1-11.
- Gozal YM, Akture E, Ravindra VM, Scoville JP, Jensen RL, Couldwell WT, Taussky P (2019 Jan 18). Defining a new neurosurgical complication classification: lessons learned from a monthly Morbidity and Mortality conference. J Neurosurg, 1-5.
- Abou-Al-Shaar H, Azab MA, Karsy M, Guan J, Couldwell WT, Jensen RL (2018 Nov). Assessment of Costs in Open Microsurgery and Stereotactic Radiosurgery for Intracranial Meningiomas. World Neurosurg, 119, e357-e365.
- Orton A, Boothe D, Evans D, Lloyd S, Monroe MM, Jensen R, Shrieve DC, Hitchcock YJ (2018 Nov 1). Esthesioneuroblastoma: A Patterns-of-Care and Outcomes Analysis of the National Cancer Database. Neurosurgery, 83(5), 940-947.
- Tiburcio PDB, Xiao B, Chai Y, Asper S, Tripp SR, Gillespie DL, Jensen RL, Huang LE (2018 Oct 12). IDH1(R132H) is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment. Oncotarget, 9(80), 35100-35113.
- Abou-Al-Shaar H, Azab MA, Karsy M, Guan J, Alzhrani G, Gozal YM, Jensen RL, Couldwell WT (2018 Oct 1). Assessment of costs in open surgery and stereotactic radiosurgery for vestibular schwannomas. J Neurosurg, 1-8.
- Guan J, Karsy M, Brock AA, Couldwell WT, Kestle JRW, Jensen RL, Dailey AT, Bisson EF, Schmidt RH (2018 Sep 1). Analysis of an overlapping surgery policy change on costs in a high-volume neurosurgical department. J Neurosurg, 1-8.
- Guan J, Karsy M, Brock AA, Couldwell WT, Kestle JRW, Jensen RL, Dailey AT, Schmidt RH (2018 Aug). Impact of a more restrictive overlapping surgery policy: an analysis of pre- and postimplementation complication rates, resident involvement, and surgical wait times at a high-volume neurosurgical department. J Neurosurg, 129(2), 515-523.
- Karsy M, Henderson F, Tenny S, Guan J, Amps JW, Friedman AH, Spiotta AM, Patel S, Kestle JRW, Jensen RL, Couldwell WT (2018 Aug 1). Attitudes and opinions of US neurosurgical residents toward research and scholarship: a national survey. J Neurosurg, 1-12.
- Sommer T, Karsy M, Driscoll MJ, Jensen RL (2018 Jul). Varicella-Zoster Virus Infection and Osteomyelitis of the Skull. World Neurosurg, 115, 297-300.
- Orton A, Frandsen J, Jensen R, Shrieve DC, Suneja G (2018 Jun). Anaplastic meningioma: an analysis of the National Cancer Database from 2004 to 2012. J Neurosurg, 128(6), 1684-1689.
- Karsy M, Azab MA, Abou-Al-Shaar H, Guan J, Eli I, Jensen RL, Ormond DR (2018 Jun). Clinical potential of meningioma genomic insights: a practical review for neurosurgeons. Neurosurg Focus, 44(6), E10.
- Karsy M, Yoon N, Boettcher L, Jensen R, Shah L, MacDonald J, Menacho ST (2018 May). Surgical treatment of glioblastoma in the elderly: the impact of complications. J Neurooncol, 138(1), 123-132.
- Frandsen J, Orton A, Jensen R, Colman H, Cohen AL, Tward J, Shrieve DC, Suneja G (2018 Apr). Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database. J Neurosurg, 128(4), 1133-1138.
- Karsy M, Burnett B, Di Ieva A, Cusimano MD, Jensen RL (2018 Mar). Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome. J Neurosurg, 128(3), 657-666.
- Karsy M, Gillespie DL, Horn KP, Burrell LD, Yap JT, Jensen RL (2018). Correlation of Glioma Proliferation and Hypoxia by Luciferase, Magnetic Resonance, and Positron Emission Tomography Imaging. Methods Mol Biol, 1742, 301-320.
- Gamboa NT, Karsy M, Gamboa JT, Yoon NK, Driscoll MJ, Sonnen JA, Salzman KL, Jensen RL (2018). Preoperative and intraoperative perfusion magnetic resonance imaging in a RELA fusion-positive anaplastic ependymoma: A case report. Surg Neurol Int, 9, 144.
- Hu N, Cheng H, Zhang K, Jensen RL (). Evaluating the prognostic accuracy of biomarkers for glioblastoma multiforme (GBM) using the Cancer Genome Atlas (TCGA) data. Cancer Inform, 16, 1-11.
- Guan J, Brock AA, Karsy M, Couldwell WT, Schmidt MH, Kestle JRW, Jensen RL, Dailey AT, Schmidt RH (2017 Nov). Managing overlapping surgery: an analysis of 1018 neurosurgical and spine cases. J Neurosurg, 127(5), 1096-1104.
- Figueroa JM, Skog J, Akers J, Li H, Komotar R, Jensen R, Ringel F, Yang I, Kalkanis S, Thompson R, LoGuidice L, Berghoff E, Parsa A, Liau L, Curry W, Cahill D, Bettegowda C, Lang FF, Chiocca EA, Henson J, Kim R, Breakefield X, Chen C, Messer K, Hochberg F, Carter BS (2017 Oct 19). Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients. Neuro Oncol, 19(11), 1494-1502.
- Jensen RL, Alzhrani G, Kestle JRW, Brockmeyer DL, Lamb SM, Couldwell WT (2017 Oct). Neurosurgeon as educator: a review of principles of adult education and assessment applied to neurosurgery. J Neurosurg, 127(4), 949-957.
- Bagshaw HP, Burt LM, Jensen RL, Suneja G, Palmer CA, Couldwell WT, Shrieve DC (2017 Jun). Adjuvant radiotherapy for atypical meningiomas. J Neurosurg, 126(6), 1822-1828.
- Huang LE, Cohen AL, Colman H, Jensen RL, Fults DW, Couldwell WT (2017 Jan 3). IGFBP2 expression predicts IDH-mutant glioma patient survival. Oncotarget, 8(1), 191-202.
- Bagshaw HP, Ly D, Jensen RL, and Shrieve DC (). Local control after stereotactic radiosurgery for melanoma brain metastases by metastatic lesion. J Radiosurg SBRT, 4, 181-190.
- Kalinina J, Ahn J, Devi NS, Wang L, Li Y, Olson JJ, Glantz M, Smith T, Kim EL, Giese A, Jensen RL, Chen CC, Carter BS, Mao H, He M, Van Meir EG (2016 Dec 15). Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase. Clin Cancer Res, 22(24), 6256-6265.
- Modzelewska K, Boer EF, Mosbruger TL, Picard D, Anderson D, Miles RR, Kroll M, Oslund W, Pysher TJ, Schiffman JD, Jensen R, Jette CA, Huang A, Stewart RA (2016 Oct 25). MEK Inhibitors Reverse Growth of Embryonal Brain Tumors Derived from Oligoneural Precursor Cells. Cell Rep, 17(5), 1255-1264.
- Hu N, Richards R, Jensen RL (). Role of chromosone 1p/19q co-deletion on the prognosis of oliogodendromagliomas: A systemic review and meta-analysis. Interdiscip Neurosurg, 5, 58-63.
- Karsy M, Hoang N, Barth T, Burt L, Dunson W, Gillespie DL, Jensen RL (2016 Feb). Combined Hydroxyurea and Verapamil in the Clinical Treatment of Refractory Meningioma: Human and Orthotopic Xenograft Studies. World Neurosurg, 86, 210-9.
- Bagshaw HP, Ly D, Suneja G, Jensen RL, Shrieve DC (2016). Local control of melanoma brain metastases treated with stereotactic radiosurgery. J Radiosurg SBRT, 4(3), 181-190.
- de Souza PC, Balasubramanian K, Njoku C, Smith N, Gillespie DL, Schwager A, Abdullah O, Ritchey JW, Fung KM, Saunders D, Jensen RL, Towner RA (2015 Dec). OKN-007 decreases tumor necrosis and tumor cell proliferation and increases apoptosis in a preclinical F98 rat glioma model. J Magn Reson Imaging, 42(6), 1582-91.
- Jensen RL (2015 Oct). Predicting Outcomes After Glioma Surgery: Model Behavior. World Neurosurg, 84(4), 894-6.
- Lloyd IE, Clement PW, Salzman KL, Jensen RL, Salama ME, Palmer CA (2015 Sep 2). An unusual and challenging case of HIV-associated primary CNS Lymphoma with Hodgkin-like morphology and HIV encephalitis. Diagn Pathol, 10(1), 152.
- Ly D, Bagshaw HP, Anker CJ, Tward JD, Grossmann KF, Jensen RL, Shrieve DC (2015 Aug). Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment. J Neurosurg, 123(2), 395-401.
- Schuster J, Lai RK, Recht LD, Reardon DA, Paleologos NA, Groves MD, Mrugala MM, Jensen R, Baehring JM, Sloan A, Archer GE, Bigner DD, Cruickshank S, Green JA, Keler T, Davis TA, Heimberger AB, Sampson JH (2015 Jun). A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study. Neuro Oncol, 17(6), 854-61.
- Karsy M, Sivakumar W, Neil J, Guan J, Moy F, Jensen RL (). Meta-analysis of the effect of isocitrate dehydrogenase 1 and 2 mutation on glioblastoma prognosis. Contemp Neurosurg, 37(5), 1-6.
- Karsy M, Neil JA, Guan J, Mahan MA, Colman H, Jensen RL (2015 Mar). A practical review of prognostic correlations of molecular biomarkers in glioblastoma. Neurosurg Focus, 38(3), E4.
- Chen R, Ravindra VM, Cohen AL, Jensen RL, Salzman KL, Prescot AP, Colman H (2015 Mar). Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas. Neurosurg Focus, 38(3), E2.
- Gillespie DL, Arce-Larreta MT, Ravichandran S, Leishman LL, Berrondo C, Gamboa J, Wang L, Wang X, Lu Z-R, Jensen RL (). RNA interference targeting HIF-1a via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model. J Neurosurg, 122(2), 331-341.
- Mazur MD, Neil JA, Agarwal C, Jensen RL, Couldwell WT (2015). Surgical management of a transosseous meningioma with invasion of torcula, superior sagittal sinus, transverse sinus, calvaria, and scalp. Surg Neurol Int, 6, 40.
- Ravindra VM, Braca JA 3rd, Jensen RL, Duckworth EA (2015). Management of intracranial pathology during pregnancy: Case example and review of management strategies. Surg Neurol Int, 6, 43.
- Choi H, Gillespie DL, Berg S, Rice C, Couldwell S, Gu J, Colman H, Jensen RL, Huang LE (2015). Intermittent induction of HIF-1alpha produces lasting effects on malignant progression independent of its continued expression. PLoS ONE, 10(4), e0125125.
- Womeldorff M, Gillespie D, Jensen RL (2014 Dec). Hypoxia-inducible factor-1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma. Neurosurg Focus, 37(6), E8.
- Kent T, Jensen RL (). Intraoperative Magnetic Resonance Imaging in Neurosurgery: Part II -- Brain Shift, Perioperative Complications, and Costs. Contemp Neurosurg, 36(23).
- Kent T, Jensen RL (). Intraoperative Magnetic Resonance Imaging in Neurosurgery: Part 1 -- A Review of History, Use, and Outcomes. Contemp Neurosurg, 36(23).
- Simon TD, Van Yserloo B, Nelson K, Gillespie D, Jensen R, McAllister JP 2nd, Riva-Cambrin J, Stockmann C, Daly JA, Blaschke AJ (2014 Feb). Use of quantitative 16S rRNA PCR to determine bacterial load does not augment conventional cerebrospinal fluid (CSF) cultures among children undergoing treatment for CSF shunt infection. Diagn Microbiol Infect Dis, 78(2), 188-95.
- Terakedis BE, Jensen RL, Shrieve DC (). Tumor Control and incidence of radiation necrosis after reirradiation with stereotactic radiosurgery for bran metastases. Journal of Radiosurgery, (3), 21-28.
- Wagner AE, Chen A, Jensen RL, Shrieve DC (). Stereotactic radiosurgery for solitary brain metastases: Factors impacting control. J Radiosurg SBRT, 3(2), 111-121.
- Ghia AJ, Tward JD, Anker CJ, Boucher KM, Jensen RL, Shrieve DC (2014). Radiosurgery for melanoma brain metastases: the impact of hemorrhage on local control. J Radiosurg SBRT, 3(1), 43-50.
- Terakedis BE, Jensen RL, Boucher K, Shrieve DC (2014). Tumor control and incidence of radiation necrosis after reirradiation with stereotactic radiosurgery for brain metastases. J Radiosurg SBRT, 3(1), 21-28.
- Ghia A, Jensen RL, Sherieve A, Hu N, Li X, Shrieve D (). Radiosurgery for melanoma brain metastases: the impact of hemorrhage on local control. Journal of Radiosurgery, (3), 43-50.
- Wagner AE, Chen A, Anker CJ, Tward JD, Ghia AJ, Jensen RL, Shrieve DC (2014). Stereotactic radiosurgery for a single brain metastasis: factors impacting control. J Radiosurg SBRT, 3(2), 111-121.
- Jensen RL, Mumert ML, Gillespie DL, Kinney AY, Schabel MC, Salzman KL (2014 Jan). Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome. Neuro Oncol, 16(2), 280-91.
- Jensen RL (). Educating our residents for the alphabet soup of PQRS and HCAHPS. AANS Neurosurgeon, 23(4).
- Towner RA, Jensen RL, Vaillant B, Colman H, Saunders D, Giles CB, Wren JD (2013 Dec). Experimental validation of 5 in-silico predicted glioma biomarkers. Neuro Oncol, 15(12), 1625-34.
- Chagovetz AA, Quinn C, Damarse N, Hansen LD, Chagovetz AM, Jensen RL (2013 Aug). Differential scanning calorimetry of gliomas: a new tool in brain cancer diagnostics? Neurosurgery, 73(2), 289-95; discussion 295.
- Grossmann KF, Colman H, Akerley WA, Glantz M, Matsuoko Y, Beelen AP, Yu M, De Groot JF, Aiken RD, Olson JJ, Evans BA, Jensen RL (2013). Erratum to: Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme. J Neurooncol, 113(1), 151.
- Towner RA, Gillespie DL, Schwager A, Saunders DG, Smith N, Njoku CE, Krysiak RS 3rd, Larabee C, Iqbal H, Floyd RA, Bourne DW, Abdullah O, Hsu EW, Jensen RL (2013 Mar). Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007. Neuro Oncol, 15(3), 330-40.
- Towner RA, Jensen RL, Colman H, Vaillant B, Smith N, Casteel R, Saunders D, Gillespie DL, Silasi-Mansat R, Lupu F, Giles CB, Wren JD (2013 Jan). ELTD1, a potential new biomarker for gliomas. Neurosurgery, 72(1), 77-90; discussion 91.
- Tran DK, Jensen RL (2013). Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities. Surg Neurol Int, 4(Suppl 3), S129-35.
- Cohen AL, Salzman K, Palmer C, Jensen R, Colman H (2013). Bevacizumab is Effective for Recurrent Papillary Tumor of the Pineal Region: First Report. Case Rep Oncol, 6(2), 434-40.
- Grossmann KF, Colman H, Akerley WA, Glantz M, Matsuoko Y, Beelen AP, Yu M, De Groot JF, Aiken RD, Olson JJ, Evans BA, Jensen RL (2012 Nov). Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme. J Neurooncol, 110(2), 257-64.
- Jensen RL, Minshew L, Shrieve AF, Hu N, Shrieve DC (). Stereotactic radiosurgery and radiotherapy for meningiomas: biomarker predictors of patient outcome and response to therapy. J Radiosurg SBRT, 2(1), 41-50.
- Towner RA, Jensen RL, Colman H, Vaillant B, Smith N, Castell R, Saunders D, Gillespie DL, Silasi-Mansat R, Lupu F, Giles CB, Wren JD (). ELTD, a Novel Biomarker for Gliomas. Neurosurgery, (72), 77-91.
- Enslow MS, Zollinger LV, Morton KA, Butterfield RI, Kadrmas DJ, Christian PE, Boucher KM, Heilbrun ME, Jensen RL, Hoffman JM (2012 Sep). Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma. Clin Nucl Med, 37(9), 854-61.
- Jensen R, Lee J (2012 Jul). Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation. Neurosurgery, 71(1), 146-56.
- Jensen R, Schiff D (2012 Jul). Comments. Neurosurgery, 71(1), 79.
- Abraham S, Hu N, Jensen R (2012 Jul). Hypoxia-inducible factor-1-regulated protein expression and oligodendroglioma patient outcome: comparison with established biomarkers and preoperative UCSF low-grade scoring system. J Neurooncol, 108(3), 459-68.
- Jensen RL, LeeJ (). Predictive biomarkers of human meningioma behavior: correlation with imaging, proliferation and outcome. Neurosurgery, (71), 146-156.
- Doblas S, He T, Saunders D, Hoyle J, Smith N, Pye Q, Lerner M, Jensen RL, Towner RA (2012 Apr). In vivo characterization of several rodent glioma models by 1H MRS. NMR Biomed, 25(4), 685-94.
- Jensen RL, Minshew L, Shrieve AF, Hu N, Shrieve DC (2012). Stereotactic radiosurgery and radiotherapy for meningiomas: biomarker predictors of patient outcome and response to therapy. J Radiosurg SBRT, 2(1), 41-50.
- Garber ST, Jensen RL (2012). Image guidance for brain metastases resection. Surg Neurol Int, 3(Suppl 2), S111-7.
- Chagovetz AA, Jensen RL, Recht L, Glantz M, Chagovetz AM (2011 Dec). Preliminary use of differential scanning calorimetry of cerebrospinal fluid for the diagnosis of glioblastoma multiforme. J Neurooncol, 105(3), 499-506.
- Lin N, Dunn IF, Glantz M, Allison DL, Jensen R, Johnson MD, Friedlander RM, Kesari S (2011 Oct). Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study. J Neurosurg, 115(4), 730-6.
- Taussky P, Kalra R, Coppens J, Mohebali J, Jensen R, Couldwell WT (2011 Jul). Endocrinological outcome after pituitary transposition (hypophysopexy) and adjuvant radiotherapy for tumors involving the cavernous sinus. J Neurosurg, 115(1), 55-62.
- Wefel JS, Cloughesy T, Zazzali JL, Zheng M, Prados M, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Das A, Friedman HS (2011 Jun). Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol, 13(6), 660-8.
- Prados M, Cloughesy T, Samant M, Fang L, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Das A, Friedman HS (2011 Jan). Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol, 13(1), 143-51.
- Chintala S, Toth K, Cao S, Durrani FA, Vaughan MM, Jensen RL, Rustum YM (2010 Oct). Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha. Cancer Chemother Pharmacol, 66(5), 899-911.
- Jensen RL, Shrieve A, Jensen P, Shrieve D (In Press). Intensity Modulated Radiosurgery for Parasellar Lesions: Technique and Long-term Outcomes. J Neurooncol.
- Sampson JH, Archer G, Pedain C, Wembacher-Schrder E, Westphal M, Kunwar S, Vogelbaum MA, Coan A, Herndon JE, Raghavan R, Brady ML, Reardon DA, Friedman AH, Friedman HS, Rodrguez-Ponce MI, Chang SM, Mittermeyer S, Croteau D, Puri RK, PRECISE Trial Investigators (). Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg, 113(2), 301-9.
- Mumert, M, Jensen EM, Jensen RL (In Press). Parafalcine lesions in the cancer patient:diagnostic dilemma meningioma or metastatic lesion. J Neurooncol, 99(1), 135-139.
- Yu Y, Blair S, Gillespie D, Jensen R, Myszka D, Badran AH, Ghosh I, Chagovetz A (2010 Jun 15). Direct DNA methylation profiling using methyl binding domain proteins. Anal Chem, 82(12), 5012-9.
- Anker CJ, Hymas RV, Hazard LJ, Jensen RL, Shrieve D (In Press). Effect of treatment volumes on patterns of failure in glioblastoma multiforme. In preparation. J Neurooncol.
- Jensen RL, Jensen PR, Shrieve AF, Hazard L, Shrieve DC (2010 Jun). Overall and progression-free survival and visual and endocrine outcomes for patients with parasellar lesions treated with intensity-modulated stereotactic radiosurgery. J Neurooncol, 98(2), 221-31.
- Schabel MC, DiBella EVR, Jensen RL, and Salzman KL (In Press). A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: II In Vivo results. Phys Med Biol, 55, 4807-4823.
- Anker CJ, Hymas RV, Hazard LJ, Boucher KM, Jensen RL, Shrieve DC (). Stereotactic radiosurgery eligibility and selection bias in the treatment of glioblastoma multiforme. J Neurooncol, 98(2), 253-263.
- Jensen RL, Shan JS, Freimark BD, Harris DA, King SW, Parseghian MH (2010). Clinical update: Treatment of glioblastoma multiforme with radiolabeled antibodies that target tumor necrosis. Current Cancer Therapy Reviews, 6(1), 13-18.
- Vredenburgh JJ, Cloughesy T, Samant M, Prados M, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Das A, Friedman HS (2010). Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study. Oncologist, 15(12), 1329-34.
- Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T (2009 Oct 1). Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol, 27(28), 4733-40.
- Soffietti R, Akerley W, Jensen RL, Bischoff J, Regierer AC (2009 Aug). The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors. Semin Oncol, 36(4 Suppl 2), S55-68.
- Chang EF, Clark A, Jensen RL, Bernstein M, Guha A, Carrabba G, Mukhopadhyay D, Kim W, Liau LM, Chang SM, Smith JS, Berger MS, McDermott MW (2009 Aug). Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. J Neurosurg, 111(2), 203-10.
- Wang XL, Xu R, Wu X, Gillespie D, Jensen R, Lu ZR (2009 May-Jun). Targeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice. Mol Pharm, 6(3), 738-46.
- Niazi TN, Jensen EM, Jensen RL (2009 Feb). WHO Grade II and III supratentorial hemispheric ependymomas in adults: case series and review of treatment options. J Neurooncol, 91(3), 323-8.
- Hazard LJ, Wang B, Skidmore TB, Chern SS, Salter BJ, Jensen RL, Shrieve DC (2009 Feb 1). Conformity of LINAC-based stereotactic radiosurgery using dynamic conformal arcs and micro-multileaf collimator. Int J Radiat Oncol Biol Phys, 73(2), 562-70.
- Gillespie DL, Flynn JR, Ragel BT, Arce-Larreta M, Kelly DA, Tripp SR, Jensen RL (2009). Silencing of HIF-1alpha by RNA interference in human glioma cells in vitro and in vivo. Methods Mol Biol, 487, 283-301.
- Soffieti R, Holmes, Akerley, Bischoff, Regierer, Jensen RL, Glantz M (). CNS Prophylaxis from solid tumors: identifying and evaluating patients at risk. Semin Oncol, (36), S55-S69.
- Samlowski WE, Majer M, Boucher KM, Shrieve AF, Dechet C, Jensen RL, Shrieve DC (2008 Nov 1). Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery. Cancer, 113(9), 2539-48.
- Ragel BT, Couldwell WT, Gillespie DL, Wendland MM, Whang K, Jensen RL (2008 Sep). A comparison of the cell lines used in meningioma research. Surg Neurol, 70(3), 295-307; discussion 307.
- Flynn JR, Wang L, Gillespie DL, Stoddard GJ, Reid JK, Owens J, Ellsworth GB, Salzman KL, Kinney AY, Jensen RL (2008 Sep 1). Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme. Cancer, 113(5), 1032-42.
- Flynn JR, Wang L, Gillespie DL, Ellsworth G, Salzman KL, Kinney A, Jensen RL (). A correlation of hypoxia response proteins, cellular proferation, angiogenesis and tumor necrosis with survival in adults with glioblastoma multiforme. Cancer, (113), 1032-1042.
- Jensen RL, Wendland MM, Chern SS, Shrieve DC (2008 May). Novalis intensity-modulated radiosurgery: methods for pretreatment planning. Neurosurgery, 62(5 Suppl), A2-9; discussion A9-10.
- Ragel BT, Elam IL, Gillespie DL, Flynn JR, Kelly DA, Mabey D, Feng H, Couldwell WT, Jensen RL (2008 Feb). A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigation. J Neurosurg, 108(2), 304-10.
- Ragel BT, Elam I, Mabey D, Gillespie D, Couldwell WT, Jensen RL (). A novel intracranial meningioma mouse model using luciferase expressing meningioma cells. J Neurosurg, (108), 304-310.
- Jensen RL, Shrieve AF, Samlowski W, Shrieve DC (2008). Outcomes of patients with brain metastases from melanoma and renal cell carcinoma after primary stereotactic radiosurgery. Clin Neurosurg, 55, 150-9.
- Wang XL, Nguyen T, Gillespie D, Jensen R, Lu ZR (2008 Jan). A multifunctional and reversibly polymerizable carrier for efficient siRNA delivery. Biomaterials, 29(1), 15-22.
- Want XL, Thanh N, Gillespie D, Jensen R, and Lu ZR (2008). A novel multifunctional and reversibly polymerizable carrier for efficient siRNA delivery. Biomaterials, 29(1), 15-22.
- Majer M, Jensen RL, Shrieve DC, Watson GA, Wang M, Leachman SA, Boucher KM, Samlowski WE (2007 Sep 15). Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases. Cancer, 110(6), 1329-37.
- Varker KA, Biber JE, Kefauver C, Jensen R, Lehman A, Young D, Wu H, Lesinski GB, Kendra K, Chen HX, Walker MJ, Carson WE 3rd (2007 Aug). A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma. Ann Surg Oncol, 14(8), 2367-76.
- Ragel BT, Jensen RL, Gillespie DL, Couldwell WT (2007). Identification of hypoxia-induced genes in a malignant glioma cell line (U251) by cDNA microarray analysis. Neurosurg Rev, 30(3), 181-187.
- Samlowski WE, Watson GA, Wang M, Rao G, Klimo P Jr, Boucher K, Shrieve DC, Jensen RL (2007 May 1). Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer, 109(9), 1855-62.
- Kan P, Liu JK, Wendland MM, Shrieve D, Jensen RL (2007 May). Peritumoral edema after stereotactic radiosurgery for intracranial meningiomas and molecular factors that predict its development. J Neurooncol, 83(1), 33-8.
- Gillespie DL, Whang K, Ragel BT, Flynn JR, Kelly DA, Jensen RL (2007 Apr 15). Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo. Clin Cancer Res, 13(8), 2441-8.
- Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT (2007 Feb 1). Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer, 109(3), 588-97.
- Wang XL, Jensen RL, and Lu ZR (01/01/2007). A Novel Environment-Sensitive Biodegradable Polydisulfide Protanable Pendants for Nucleic Acid Delivery. J Control Release, (120), 250-258.
- Ragel BT, Couldwell WT, Wurster RD, Jensen RL (2007). Chronic suppressive therapy with calcium channel antagonists for refractory meningiomas. Neurosurg Focus, 23(4), E10.
- Ragel BT, Gillespie DL, Kushnir V, Polevaya N, Kelly D, Jensen RL (2006 Nov). Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro. Neurosurgery, 59(5), 1109-20; discussion 1120-1.
- Rong Y, Hu F, Huang R, Mackman N, Horowitz JM, Jensen RL, Durden DL, Van Meir EG, Brat DJ (2006 Jul 15). Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res, 66(14), 7067-74.
- Jensen RL, Ragel BT, Whang K, Gillespie D (2006 Jul). Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. J Neurooncol, 78(3), 233-47.
- Rao G, Klimo P Jr, Jensen RL, MacDonald JD, Couldwell WT (2006 May). Surgical strategies for recurrent craniofacial meningiomas. Neurosurgery, 58(5), 874-80; discussion 874-80.
- Ragel BT, Osborn AG, Whang K, Townsend JJ, Jensen RL, Couldwell WT (2006 May). Subependymomas: an analysis of clinical and imaging features. Neurosurgery, 58(5), 881-90; discussion 881-90.
- Jensen R, ORourke D, Warnick R, Sawaya R (2006 May). Resident training in neurosurgical oncology: results of the survey of North American training programs by the AANS/CNS Section on Tumors. J Neurooncol, 77(3), 241-6.
- Layfield LJ, Willmore C, Tripp S, Jones C, Jensen RL (2006 Mar). Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors. Appl Immunohistochem Mol Morphol, 14(1), 91-6.
- Kan P, Gottfried O, Liu JK, Blumenthal D, Townsend J, Jensen RL (). Primary Yolk Sac Tumor of the Conus Medullaris: Case Report and Review of the Literature. J Neurooncol, 78, 249-253.
- Rong Y, Hu F, Huange R, Mackman N, Horowitz JM, Jensen RL, Durden DL Van Meir EG, Brat DJ (). Egr-1 regulateds hypoxia-induced expression of tissue factor in blioblastoma through HIF-1 independent mechanisms. Cancer Res, 66, 7067-7074.
- Rogers LR, Sills AK, Vogelbaum MA, Suh JH, Rock JP, Ellis TI, Stieber VW Asher AL, Fraser RW, Billingsley JS, Arrambid S, Jensen RL (2006). Initial results of phase II study utilizing the Gliasite RTS for the treatment of a resected single brain metastasis. J Neurosurg, 105(375), 384.
- Chern SS, Leavitt DD, Jensen R Shrieve DC (2006). Is smaller better? Comparison of 3 mm and 5 mm leaf size for stereotactic radiosurgery: A dosimetry study. Int J Radiat Oncol Biol Phys, 66(4 suppl), S76-81.
- Rao G, Klimo P, Thompson CJ, Samlowski W, Chang M, Watson G, Shrieve D Jensen RL (2006). Stereotactic radiosurgery as therapy for melanomas, renal carcinoma, and sarcoma brain metastases: Impact of added surgical resection and whole brain radiotherapy. Int J Radiat Oncol Biol Phys, 66(4), Suppl.
- Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT (2005 Sep). Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. J Neurosurg, 103(3), 508-17.
- Patel SJ, Shapiro WR, Laske DW, Jensen RL, Asher AL, Wessels BW, Carpenter SP, Shan JS (2005 Jun). Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients. Neurosurgery, 56(6), 1243-52; discussion 1252-3.
- Ragel B, Jensen RL, Gillespie D, Prescott S, Couldwell WT (). Cyclooxygenase-2 (COX-2) Is Ubiquitously Expressed in Meningiomas and Treatment in Vitro and COX-2 Inhibitor Celecoxib Decrease Cell Growth: Potential Therapeutic Application. J Neurosurg, 103, 508-517.
- Jensen RL, Camano E, Jensen EM, Couldwell WT (). Mesial temporal lobe lesion with new onset of gadolinium enhancement after 15 years of observation but at surgery found to be a ganglioglioma. J Neurooncol, 74.
- Shrieve DC, Hazard L, Boucher K, Jensen RL (2004 Nov). Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance. J Neurosurg, 101 Suppl 3, 390-5.
- Gilbert ME, Shelton C, McDonald A, Salzman KL, Harnsberger HR, Sharma PK, Jensen RL (2004 Jan). Meningioma of the jugular foramen: glomus jugulare mimic and surgical challenge. Laryngoscope, 114(1), 25-32.
- Ragel B and Jensen RL (2004). Pathophysiology of Meningiomas. Seminars in Neurosurgery, 14, 169-185.
- Kan P, Shelton C, Townsend J, Jensen R (2003 Aug). Primary Malignant Cerebellopontine Angle Melanoma Presenting as a Presumed Meningioma: Case Report and Review of the Literature. Skull Base, 13(3), 159-166.
- Liu JK, Schmidt MH, MacDonald JD, Jensen RL, Couldwell WT (2003 May 15). Hypophysial transposition (hypophysopexy) for radiosurgical treatment of pituitary tumors involving the cavernous sinus. Technical note. Neurosurg Focus, 14(5), e11.
- Jensen RL, Soleau S, Bhayani MK, Christiansen D (2002 Sep). Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas. J Neurosurg, 97(3), 658-67.
- Jensen RL, Wurster RD (2001 May). Calcium channel antagonists inhibit growth of subcutaneous xenograft meningiomas in nude mice. Surg Neurol, 55(5), 275-83.
- Shrieve DC, Watson GA, Jensen RL, and Leavitt DL (2001). Conformity of LINAC-based steriotactic radiosurgery using dynamic conformal arcs and mini-multileaf collimator. Int J Radiat Oncol Biol Phys, 51(Suppl 1), 126.
- Galloway EB 3rd, Jensen RL, Dailey AT, Thompson BG, Shelton C (2000 Nov). Role of topical steroids in reducing dysfunction after nerve injury. Laryngoscope, 110(11), 1907-10.
- Jensen RL, Petr M, Wurster RD (2000 Mar). Calcium channel antagonist effect on in vitro meningioma signal transduction pathways after growth factor stimulation. Neurosurgery, 46(3), 692-702; discussion 702-3.
- Jellish WS, Jensen RL, Anderson DE, Shea JF (1999 Oct). Intraoperative electromyographic assessment of recurrent laryngeal nerve stress and pharyngeal injury during anterior cervical spine surgery with Caspar instrumentation. J Neurosurg, 91(2 Suppl), 170-4.
- Jensen RL, Leppla D, Rokosz N, Wurster RD (1998 Jan). Matrigel augments xenograft transplantation of meningioma cells into athymic mice. Neurosurgery, 42(1), 130-5; discussion 135-6.
- Jensen RL, Stone JL (1997 Jul). Benjamin Winslow Dudley and early American trephination for posttraumatic epilepsy. Neurosurgery, 41(1), 263-8.
- Jensen RL, Hahn YS, Ciro E (1997 Jan). Risk factors of intracranial pressure monitoring in children with fiberoptic devices: a critical review. Surg Neurol, 47(1), 16-22.
- Jensen RL, Stone JL, Hayne RA (1996 Mar). Introduction of the human Horsley-Clarke stereotactic frame. Neurosurgery, 38(3), 563-7; discussion 567.
- Jensen RL, Lee YS, Guijrati M, Origitano TC, Wurster RD, Reichman OH (1995 Nov). Inhibition of in vitro meningioma proliferation after growth factor stimulation by calcium channel antagonists: Part II--Additional growth factors, growth factor receptor immunohistochemistry, and intracellular calcium measurements. Neurosurgery, 37(5), 937-46; discussion 946-7.
- Jensen RL, Origitano TC, Lee YS, Weber M, Wurster RD (1995 Feb). In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. Neurosurgery, 36(2), 365-73; discussion 373-4.
- Sherrod BA, Gamboa NT, Wilderson C, Wilde H, Azab MA, Karsy M, Jensen RL, Menacho ST (). Effect of patient age on glioblastoma treatment costs: a Value Driven Outcome database analysis. J Neurooncol.
- Sherrod BA, Gamboa NT, Wilderson C, Wilde H, Azab MA, Karsy M, Jensen RL, Menacho ST (). Effect of patient age on glioblastoma treatment costs: a Value Driven Outcome database analysis. J Neurooncol.
- Karsy M, Jensen MR, Guan J, Ravindra V, Bisson E, Couldwell WT (). EQ-5D quality-of-life analysis and cost-effectiveness after skull base meningioma resection. Neurosurgery.
Review
- Karsy M, Gillespie DL, Horn K, Harper JB, Ruesch M, Yap J, Jensen RL (). Magnetic Resonance Imaging of Hypoxia in Primary Central Nervous System Tumors: Part 2. [Review]. Contemp Neurosurg, 40(13), 1-8.
- Karsy M, Gillespie DL, Horn K, Guan J, Brock AA, Jensen RL (). Magnetic Resonance Imaging (MRI) of Hypoxia in Primary Central Nervous System Tumors: Part 1. [Review]. Contemp Neurosurg, 40(12), 1-8.
- Karsy M, Guan J, Cohen AL, Jensen RL, Colman H (2017 Feb). New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M. [Review]. Curr Neurol Neurosci Rep, 17(2), 19.
- Karsy M, Guan J, Cohen A, Colman H, Jensen RL (2016 Apr). Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons. [Review]. Neurosurg Clin N Am, 27(2), 249-60.
- Karsy M, Guan J, Jensen R, Huang LE, Colman H (2016 Apr). The Impact of Hypoxia and Mesenchymal Transition on Glioblastoma Pathogenesis and Cancer Stem Cells Regulation. [Review]. World Neurosurg, 88, 222-36.
- Zlotnick D, Kalkanis SN, Quinones-Hinojosa A, Chung K, Linskey ME, Jensen RL, DeMonte F, Barker FG, Racine CA, Berger MS, Black PM, Cusimano M, Sekhar LN, Parsa A, Aghi M, McDermott MW (2010 Sep). FACT-MNG: tumor site specific web-based outcome instrument for meningioma patients. [Review]. J Neurooncol, 99(3), 423-31.
- Ragel BT, Jensen RL (2010 Sep). Aberrant signaling pathways in meningiomas. [Review]. J Neurooncol, 99(3), 315-24.
- Jensen RL (2009 May). Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. [Review]. J Neurooncol, 92(3), 317-35.
- Samlowski WE, Jensen RL, Shrieve DC (2007 Dec). Multimodality management of brain metastases in metastatic melanoma patients. [Review]. Expert Rev Anticancer Ther, 7(12), 1699-705.
- Ragel BT, Jensen RL, Couldwell WT (2007). Inflammatory response and meningioma tumorigenesis and the effect of cyclooxygenase-2 inhibitors. [Review]. Neurosurg Focus, 23(4), E7.
- Jensen RL (2006 Apr 15). Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures. [Review]. Neurosurg Focus, 20(4), E24.
- Ragel BT, Jensen RL (2005 Nov 15). Molecular genetics of meningiomas. [Review]. Neurosurg Focus, 19(5), E9.
- Hazard LJ, Jensen RL, Shrieve DC (2005 Aug). Role of stereotactic radiosurgery in the treatment of brain metastases. [Review]. Am J Clin Oncol, 28(4), 403-10.
- Jensen RL (2004 Jun 15). Cauda equina syndrome as a postoperative complication of lumbar spine surgery. [Review]. Neurosurg Focus, 16(6), e7.
- Ragel B, Jensen RL (2003 Mar-Apr). New approaches for the treatment of refractory meningiomas. [Review]. Cancer Control, 10(2), 148-58.
- Jensen RL (1998 Feb). Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review. [Review]. Surg Neurol, 49(2), 189-95; discussion 196.
- Jensen RL, Stone JL, Hayne R (1995). Use of the Horsley-Clarke stereotactic frame in humans. [Review]. Stereotact Funct Neurosurg, 65(1-4), 194-7.
Edited Book
- Zada G, Jensen RL (Eds.) (). Neurosurgery Clinics of North America.
- G Zada, RL Jensen (Eds.) (). Neurosurgery Clinics of North America.
- MW McDrmott, Pk Sneed, K Huang, L Ma, RL Jensen, I Paddick (Eds.) (). Radiosurgery. (Vol. 7). Karger.
Book Chapter
- Weaver BD, Jensen RL (). Hemangiopericytoma. In Lonser R, Elder B (Eds.), Cases in Surgical Neuro-oncology. New York: Oxford University Press.
- Weaver BD, Jensen RL (). Posterior fossa metastases. In Couldwell WT (Ed.), Skull Base Surgery of the Posterior Fossa. New York: Springer.
- Jensen RL (). Editorial: "Postoperative radiotherapy in the treatment of single metastases to the brain" by Patchell et al. In Bendok B, Ghogawala Z, El Tecle N, Ragel B, Asthagiri A, Resnick D (Eds.), CNS Essential Papers in Neurosurgery. Schaumburg, IL: CNS.
- Rainey J, Jensen RL (). Meningioma models. In RM Murillo, A Martinez (Eds.), Animal Models of Brain Tumors. New York: Springer.
- Ragel B, Jensen RL (). Intracranial Meningomas in Mice: Noninvasive Bioluminescence Imaging. In Meningiomas and Schwannomas (Eds.), Tumors of the Central Nervous System (7, pp. 79-86). London: Springer.
- Jensen RL and Chkheidze R (). The role of glucose transporter-1 (Glut-1) in malignant gliomas. In MA Hayat (Ed.), Tumors of the Central Nervous System: Gliomas: glioblastoma (1). New York: Springer.
- Ragel BR, Jensen RL (). Molecular biology of meningiomas: Tumorigenesis and growth. In MW McDermott and F DeMonte (Eds.), Al-Mefty's Meningiomas. New York: Thieme.
- Ragel B, Jensen RL (). Biology of Meningiomas in Meningiomas. In Ed Al Mefty, Demonte and McDermott (Eds.). Thieme.
- Gillespie DL, Flynn JR, Ragel BT, Arcre-Larreta M, Kelly DA, Tripp SR, Jensen RL (). Silencing of HIF-1 by RNA interference in human glioma cells in vitro and in vivo. In In Methods in Molecular Biology: siRNA and miRNA silencing (M Sioud, 14). New York: Humana Press.
- Burnett B, Womeldorff M, Jensen RL (). Meningioma: Signaling Pathways and Tumor Growth. In McDermott, Theodosopoulos (Eds.), Handbook of Neurology: Meningiomas. Philadelphia: Elsevier.
- Jensen RL (). Awake craniotomy for resection of brain tumor using intraoperative cortical mapping and intraoperative magnetic resonance imaging. In Masters of Neurosurgery.
- Abou Al-Shaar H, Jensen RL, Couldwell WT (). Primary central nervous system lymphoma. In Nader R, Sabbagh A (Eds.), Neurosurgery Case Review. New York: Thieme.
Case Report
- Mumert ML, Jensen EM, Jensen R (2010 Aug). Parafalcine lesions in the cancer patient: diagnostic dilemma--meningioma or metastatic lesion? J Neurooncol, 99(1), 135-9.
- Mumert ML, Walsh M, Jensen RL (2009). Pleomorphic liposarcoma originating from intracranial dura mater. J Neurooncol, 97(1), 149-153.
- Niazi T, Jensen RL (11/01/2008). Suparatentorial ependymoma and anaplastic ependymoma. Case reports and literature review. J Neurooncol, 91, 323-328.
- Duhon B, Renner D, and Jensen R (2008). Primary CNS angiitis presenting as short-term memory loss: A case report and brief review of the literature. International Journal of Rheumatic Diseases, 11, 303-307.
- Finn MA, Blumenthal DT, Salzman KL, Jensen RL (2007 Mar). Transient postictal MRI changes in patients with brain tumors may mimic disease progression. Surg Neurol, 67(3), 246-50; discussion 250.
- McCall T, Rao G, Jensen R (2006 Nov). Development and rapid growth of a desmoid tumor in the surgical corridor after suboccipital craniotomy for recurrent low-grade astrocytoma. J Neurooncol, 80(2), 167-70.
- Blumenthal DT, Salzman KL, Digre KB, Jensen RL, Dunson WA, Dalmau J (2006 Jul 11). Early pathologic findings and long-term improvement in anti-Ma2-associated encephalitis. Neurology, 67(1), 146-9.
- McCall T, Binning M, Blumenthal DT, Jensen RL (2006 Jul). Variations of disseminated choroid plexus papilloma: 2 case reports and a review of the literature. Surg Neurol, 66(1), 62-7; discussion 67-8.
- Kan P, Gottfried ON, Blumenthal DT, Liu JK, Salzman KL, Townsend J, Jensen RL (2006 Jul). Primary spinal yolk sac tumor with brain metastasis: case report and review of the literature. J Neurooncol, 78(3), 249-53.
- Ragel BT, Blumenthal DT, Browd SR, Salzman KL, Jensen RL (2006 Jun). Intracerebral amyloidoma can mimic high-grade glioma on magnetic resonance imaging and spectroscopy. Arch Neurol, 63(6), 906-7.
- Jensen RL, Caamano E, Jensen EM, Couldwell WT (2006 May). Development of contrast enhancement after long-term observation of a dysembryoplastic neuroepithelial tumor. J Neurooncol, 78(1), 59-62.
- House P, Salzman KL, Osborn AG, MacDonald JD, Jensen RL, Couldwell WT (2004 May). Surgical considerations regarding giant dilations of the perivascular spaces. J Neurosurg, 100(5), 820-4.
- Kan P, Gottfried O, Blumenthal DT, Townsend JJ, Drozd-Borysiuk E, Brothman AR, Jensen RL (2004 Apr). Oligodendroglioma and juvenile pilocytic astrocytoma presenting as synchronous primary brain tumors. Case report with histological and molecular differentiation of the tumors and review of the literature. J Neurosurg, 100(4), 700-5.
- Jensen RL, Gillespie D, House P, Layfield L, Shelton C (2004 Mar). Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression. J Neurosurg, 100(3), 488-97.
- Liu JK, ONeill B, Orlandi RR, Moscatello AL, Jensen RL, Couldwell WT (2003 Oct). Endoscopic-assisted craniofacial resection of esthesioneuroblastoma: minimizing facial incisions--technical note and report of 3 cases. Minim Invasive Neurosurg, 46(5), 310-5.
- Rao G, Jensen RL (2003 Jan). Coexistent cerebral metastasis and cavernous malformation. J Neurol Neurosurg Psychiatry, 74(1), 105.
- Kristopaitis T, Jensen R, Gujrati M (1999 Apr). Clostridium perfringens: a rare cause of postoperative spinal surgery meningitis. Surg Neurol, 51(4), 448-50; discussion 450-1.
Editorial
- Zada G, Jensen RL (2016 Apr). Meningiomas: An Update on Diagnostic and Therapeutic Approaches. Neurosurg Clin N Am, 27(2), xiii.
- Jensen RL (2014 Oct). Navigated transcranial magnetic stimulation: another tool for preoperative planning for patients with motor-eloquent brain tumors. Neuro Oncol, 16(10), 1299-300.
Letter
Abstract
- Frandsen J, Orton A, Shrieve DS, Jensen RL, Colman H, Cohen H, Tward J, and Suneja G (). U.S. patterns of care and outcomes for gliosarcoma; a National Cancer Database Project [Abstract]. Int J Radiat Oncol Biol Phys, 96(2 suppl), E96.
- Watson G, Jensen RL (2003). Effect of hRAD51 dominant negative mutant expression in a glioblastoma model system: altered sensitivity to ionizing radiation [Abstract]. Int J Radiat Oncol Biol Phys, 57(2 Suppl), S145.
Global Impact
Selected Provider Publications
Journal Article
Tran DK, Jensen RL (2013). Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities. Surg Neurol Int, 4(Suppl 3), S129-35.
Global Impact: Global.Garber ST, Jensen RL (2012). Image guidance for brain metastases resection. Surg Neurol Int, 3(Suppl 2), S111-7.
Global Impact: Global.